Sanaria gets $4M in gov’t funds for malaria vaccine

Sanaria has snagged a research grant worth more than $4 million from the Army to work on a malaria vaccine, which the biotech company hopes to have in human testing a year from now.

Rockville-based Sanaria, which is run by two former executives of Celera Genomics, has received a total of $10 million in grants from the military and the National Institutes of Health since its founding in 2003.

CEO Stephen Hoffman says the company is on track to secure $20 million to $30 million in new research funds in the next few months.